Persistent T cell unresponsiveness associated with chronic visceral leishmaniasis in HIV-coinfected patients

Author:

de Vrij Nicky1ORCID,Rezende Antonio2,Pollmann Julia3ORCID,Meneses Ana4,Pham Thao-Thy1,Hailemichael Wasihun5,Kassa Mekebib5,Bogale Tadfe5,Melkamu Roma5,Yeshanew Arega5,Mohammed Rezika5,Diro Ermias5ORCID,Maes Ilse,Domagalska Malgorzata6,Landuyt Hanne1,Vogt Florian7,Henten Saskia van1ORCID,Laukens Kris8ORCID,Cuypers Bart9ORCID,Meysman Pieter8ORCID,Beyene Hailemariam10,Sisay Kasaye10,Kibret Aderajew10,Mersha Dagnew10,Ritmeijer Koert10,Griensven Johan Van6,Adriaensen Wim6ORCID

Affiliation:

1. Institute of Tropical Medicine

2. Aggeu Magalhães Institute – FIOCRUZ/PE

3. University Hospital Heidelberg - National Center for Tumor Diseases (NCT) Heidelberg

4. Université de Montréal

5. University of Gondar

6. Institute of Tropical Medicine Antwerp

7. The Australian National University

8. University of Antwerp

9. Biomedical informatics research network Antwerp

10. Médecins Sans Frontières

Abstract

Abstract A large proportion of HIV-coinfected visceral leishmaniasis (VL) patients exhibit a chronic disease course with frequent recurrence of VL, despite successful viral suppression and initial parasitological cure. Due to a hard-to-reach population, knowledge on immunological determinants underlying this chronic disease course is scarce, limiting treatment and patient management options. Thus, we studied alterations in cellular immunity with flow cytometry and single-cell RNA and T cell receptor sequencing on circulatory immune cells of a longitudinal HIV cohort in North-West Ethiopia, including asymptomatically Leishmania-infected and active VL-HIV patients. We observed that VL chronicity in VL-HIV patients was associated with persistent CD8+ T cell exhaustion and marked CD4+ T cell anergy, characterised by a high expression of PD-1 and TIGIT, and a lack of lymphoproliferative response upon stimulation. These findings provide a strong rationale for adjunctive immunotherapy for the treatment of chronic VL-HIV patients and highlight the importance of VL relapse markers.

Publisher

Research Square Platform LLC

Reference55 articles.

1. World neglected tropical diseases day;Hotez PJ;PLoS Negl. Trop. Dis.,2020

2. Burza, S., Croft, S.L., Boelaert, M.: Leishmaniasis. Lancet. 392, 951–970 (2018)

3. World Health Organization (WHO):. Leishmaniasis. (2022). https://www.who.int/news-room/fact-sheets/detail/leishmaniasis

4. Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients;Adriaensen W;Front. Immunol.,2017

5. HIV-1 protease inhibitors for treatment of visceral leishmaniasis in HIV-co-infected individuals;Griensven J;Lancet Infect. Dis.,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3